Separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution
We provide whole exome DNA sequening data in fastq format for 23 clinical samples of chronic myeloid leukemia stem cells (CML-SC) plus two buccal swipes derived normal samples. CML samples are comprised of 4 to 8 replicates from two patients, at diagnosis and after treatment. Single CML stem cells before treatment and single non-transformed hematopoietic stem cells (HSC) at remission were selected from bone marrow samples by FACS, according to newly identified genetic markers CD33+CD26+ at diagnosis and CD33+CD26-/CD33-CD26- at remission. WES libraries of colony forming assays derived CML-SC and HSC populations were prepared using Agilent SureSelect Human All Exon V6 kit and sequenced running 150 cycles (2x 75bp paired-end) on an Illumina NextSeq 500 platform.
- 25 samples
- DAC: EGAC00001003028
- Technology: NextSeq 500
Access to sequencing reads is available by application to the "CML-SC and HSC" study data access committee.
The "CML-SC and HSC" data access committee will consider applications for access to data sets stored in the European Genome-phenome Archive (EGA). Access to data will be granted to qualified researchers for appropriate use. A qualified researcher refers to a scientist who is employed, or a student enrolled at, or legitimately affiliated with an academic, non-profit or government institution, or a commercial company. Each application will be assessed to determine if: - It has been submitted by a qualified researcher or researchers, embedded in a recognised research institution that can provide institutional responsibility for appropriate research governance - The project described constitutes biomedical research in the context of the consent process; It breaches any of the ethical permissions or restrictions in the consent forms for any samples - It has the potential to produce information that will enable identification of individual participants
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
Other |